Santen Pharmaceutical Co. Ltd. (4536.TO)
Japan
1st Half Ended September 30
GROUP 2021 2020
Revenue Y128.76 bln Y118.91 bln
Operating Profit Y18.81 bln Y18.69 bln
Pretax Profit Y18.39 bln Y18.35 bln
Net Profit Y14.31 bln Y13.81 bln
Per share
Earnings Y35.79 Y34.58
Diluted Earnings Y35.73 Y34.50
Results are based on IFRS accounting standards.
This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.